Glaukos Income After Taxes 2014-2024 | GKOS
Glaukos annual/quarterly income after taxes history and growth rate from 2014 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- Glaukos income after taxes for the quarter ending December 31, 2024 was $-0.034B, a 8.7% decline year-over-year.
- Glaukos income after taxes for the twelve months ending December 31, 2024 was $-0.146B, a 8.7% increase year-over-year.
- Glaukos annual income after taxes for 2024 was $-0.146B, a 8.7% increase from 2023.
- Glaukos annual income after taxes for 2023 was $-0.135B, a 35.75% increase from 2022.
- Glaukos annual income after taxes for 2022 was $-0.099B, a 100.02% increase from 2021.
| Glaukos Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $-146 |
| 2023 | $-135 |
| 2022 | $-99 |
| 2021 | $-50 |
| 2020 | $-120 |
| 2019 | $15 |
| 2018 | $-13 |
| 2017 | $0 |
| 2016 | $5 |
| 2015 | $-38 |
| 2014 | $-14 |
| 2013 | $-14 |
| Glaukos Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-34 |
| 2024-09-30 | $-21 |
| 2024-06-30 | $-51 |
| 2024-03-31 | $-41 |
| 2023-12-31 | $-37 |
| 2023-09-30 | $-30 |
| 2023-06-30 | $-33 |
| 2023-03-31 | $-35 |
| 2022-12-31 | $-31 |
| 2022-09-30 | $-28 |
| 2022-06-30 | $-46 |
| 2022-03-31 | $5 |
| 2021-12-31 | $-22 |
| 2021-09-30 | $6 |
| 2021-06-30 | $-17 |
| 2021-03-31 | $-16 |
| 2020-12-31 | $-11 |
| 2020-09-30 | $-16 |
| 2020-06-30 | $-40 |
| 2020-03-31 | $-54 |
| 2019-12-31 | $37 |
| 2019-09-30 | $-14 |
| 2019-06-30 | $-6 |
| 2019-03-31 | $-1 |
| 2018-12-31 | $2 |
| 2018-09-30 | $-7 |
| 2018-06-30 | $-5 |
| 2018-03-31 | $-3 |
| 2017-12-31 | $1 |
| 2017-09-30 | $1 |
| 2017-06-30 | $-3 |
| 2017-03-31 | $1 |
| 2016-12-31 | $0 |
| 2016-09-30 | $1 |
| 2016-06-30 | $2 |
| 2016-03-31 | $1 |
| 2015-12-31 | $-2 |
| 2015-09-30 | $-2 |
| 2015-06-30 | $-33 |
| 2015-03-31 | $-1 |
| 2014-12-31 | $-5 |
| 2014-09-30 | $-2 |
| 2014-06-30 | $-2 |
| 2014-03-31 | $-4 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $5.001B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||